Carol A. Surface - Aug 2, 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role: SVP, Chief HR Officer
Signature: /s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol: MDT
Transactions as of: Aug 2, 2021
Transactions value $: -$524,846
Form type: 4
Date filed: 8/4/2021, 06:25 PM
Next filing: Mar 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDT	Ordinary Shares	Tax liability	-$525K	-4K	-11.53%	$131.31	30.7K	Aug 2, 2021	Direct	F1
transaction	MDT	Ordinary Shares	Award	$0	+3.66K	+11.92%	$0.00	34.3K	Aug 2, 2021	Direct	F2
holding	MDT	Ordinary Shares						567	Aug 2, 2021	NQ Ret Plan Sup	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDT	Stock Option (Right to Buy)	Award	$0	+31.2K		$0.00	31.2K	Aug 2, 2021	Ordinary Shares	31.2K	$131.26	Direct	F4
transaction	MDT	Stock Option (Right to Buy)	Award	$0	+1.09K		$0.00	1.09K	Aug 2, 2021	Ordinary Shares	1.09K	$131.26	Direct	F4
transaction	MDT	Performance Share Units	Award	$0	+9.14K		$0.00	9.14K	Aug 2, 2021	Performance Share Units	9.14K		Direct	F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This balance increased by 517 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
F2	The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F3	Between December 28, 2020 and June 30, 2021, the reporting person acquired 8 shares of MDT common stock under the Medtronic NQ Retirement Plan. The information in this report is based on a statement dated as of June 30, 2021.
F4	These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F5	Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6	The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,143 shares will be issued. The actual number of shares to be issued could range from a low of 1,829 at minimum performance to a high of 18,286 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F7	Vests on August 2, 2024.